ZA783492B - Cyclic amino acids - Google Patents
Cyclic amino acidsInfo
- Publication number
- ZA783492B ZA783492B ZA00783492A ZA783492A ZA783492B ZA 783492 B ZA783492 B ZA 783492B ZA 00783492 A ZA00783492 A ZA 00783492A ZA 783492 A ZA783492 A ZA 783492A ZA 783492 B ZA783492 B ZA 783492B
- Authority
- ZA
- South Africa
- Prior art keywords
- amino acids
- cyclic amino
- cyclic
- acids
- amino
- Prior art date
Links
- -1 Cyclic amino acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2574077 | 1977-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA783492B true ZA783492B (en) | 1979-06-27 |
Family
ID=10232513
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA00783492A ZA783492B (en) | 1977-06-20 | 1978-06-19 | Cyclic amino acids |
| ZA00783493A ZA783493B (en) | 1977-06-20 | 1978-06-19 | Improvement in or relating to heterocyclic compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA00783493A ZA783493B (en) | 1977-06-20 | 1978-06-19 | Improvement in or relating to heterocyclic compounds |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US4278676A (de) |
| EP (4) | EP0028017A1 (de) |
| JP (2) | JPS5436275A (de) |
| AT (1) | AT368505B (de) |
| AU (2) | AU3724478A (de) |
| CA (1) | CA1107736A (de) |
| DK (2) | DK270278A (de) |
| ES (2) | ES470912A1 (de) |
| FI (2) | FI781955A7 (de) |
| IE (1) | IE47200B1 (de) |
| IT (2) | IT7868449A0 (de) |
| NO (3) | NO782128L (de) |
| NZ (1) | NZ187615A (de) |
| ZA (2) | ZA783492B (de) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3145474A1 (de) * | 1980-11-27 | 1982-09-02 | Kefalas A/S, Koebenhavn-Valby | 3-substituierte 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridinverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| DE3145473A1 (de) * | 1980-11-27 | 1982-08-26 | Kefalas A/S, Koebenhavn-Valby | 2-substituierte 4,5,6,7-tetrahydroisoxazolo (5,4-c) pyridin-3-on-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| EP0083378A1 (de) * | 1981-12-22 | 1983-07-13 | Chugai Seiyaku Kabushiki Kaisha | Tetrahydronicotinsäureamide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
| GB8314391D0 (en) * | 1983-05-24 | 1983-06-29 | Kefalas As | Heterocyclic compounds |
| IT1228426B (it) * | 1987-07-20 | 1991-06-17 | Ausimont Spa | Perossiacidi eterociclici |
| US4859666A (en) * | 1988-07-06 | 1989-08-22 | Bristol-Myers Company | THAZ derivatives for enhancement of cerebral function |
| CN1043051C (zh) * | 1994-07-22 | 1999-04-21 | 国际壳牌研究有限公司 | 制备氢化石蜡的方法 |
| EP1641456B1 (de) | 2003-06-25 | 2010-03-03 | H. Lundbeck A/S | Gaboxadol zur behandlung von depressionen und anderen affektiven störungen |
| US20050234093A1 (en) * | 2003-06-25 | 2005-10-20 | H. Lundbeck A/S | Treatment of depression and other affective disorders |
| AR045540A1 (es) * | 2003-09-05 | 2005-11-02 | Lundbeck & Co As H | Metodo de elaboracion de 4,5,6,7 tetrahidroisoxazol [5,4-c] piridin-3-ol (thip) |
| WO2005060968A1 (en) | 2003-12-11 | 2005-07-07 | Sepracor Inc. | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| US20050137222A1 (en) * | 2003-12-18 | 2005-06-23 | H. Lundbeck A/S | Treatment of insomnia in human patients |
| US20050215521A1 (en) * | 2003-12-22 | 2005-09-29 | Karim Lalji | Modafinil combination therapy for improving sleep quality |
| EP1696959A2 (de) * | 2003-12-24 | 2006-09-06 | Sepracor, Inc. | Melatonin-kombinationstherapie zur verbesserung der schlafqualität |
| GB0402118D0 (en) * | 2004-01-30 | 2004-03-03 | Merck Sharp & Dohme | Polymorphic forms of a GABAA agonist |
| CA2556870C (en) * | 2004-02-18 | 2014-01-28 | Timothy J. Barberich | Dopamine-agonist combination therapy for improving sleep quality |
| GB0417558D0 (en) * | 2004-08-06 | 2004-09-08 | Merck Sharp & Dohme | Novel combination therapy |
| EP1848420A4 (de) * | 2005-01-28 | 2008-01-23 | Merck & Co Inc | Polymorphe formen eines gabaa-agonisten |
| EP1906953A4 (de) * | 2005-04-29 | 2009-05-20 | Lundbeck & Co As H | Säure- und basensalzformen von gaboxadol |
| JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | ムスカリン性受容体調節による神経発生 |
| EP2258359A3 (de) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin |
| US7985756B2 (en) | 2005-10-21 | 2011-07-26 | Braincells Inc. | Modulation of neurogenesis by PDE inhibition |
| WO2007053596A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20070203216A1 (en) * | 2006-02-14 | 2007-08-30 | Bjarke Ebert | Method of treating inflammatory diseases |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| WO2007134136A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| EP2068872A1 (de) | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Kombinationen mit einem 4-acylaminopyridin-derivat |
| US20100193652A1 (en) * | 2009-02-02 | 2010-08-05 | William Stajos | Wall Display System And Method Of Providing The Same |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| US8784835B2 (en) * | 2012-07-02 | 2014-07-22 | Trent Austin | Method for producing muscimol and/or reducing ibotenic acid from amanita tissue |
| CN104974175A (zh) * | 2014-04-11 | 2015-10-14 | 天津药物研究院 | 一种氨甲基羟异恶唑类似物的制备方法 |
| ES2876350T3 (es) | 2014-06-06 | 2021-11-12 | Ovid Therapeutics Inc | Métodos para aumentar la inhibición tónica y tratamiento del insomnio secundario |
| DK3274331T3 (da) * | 2015-03-24 | 2020-03-23 | H Lundbeck As | Fremstilling af 4,5,6,7-tetrahydroisozaxolo[5,4-c]pyridin-3-ol |
| US9682069B2 (en) | 2015-07-17 | 2017-06-20 | Ovid Therapeutics Inc | Methods of treating Dravet syndrome |
| KR20240160666A (ko) | 2015-07-17 | 2024-11-11 | 오비드 테라퓨틱스 인크. | 가복사돌로 발달장애들을 치료하는 방법들 |
| US9399034B1 (en) | 2015-08-11 | 2016-07-26 | Ovid Therapeutics Inc | Methods of sedation during critical care treatment |
| EP4233861A3 (de) | 2016-08-11 | 2023-10-11 | Ovid Therapeutics, Inc. | Zusammensetzungen zur behandlung von essentiellem tremor |
| US10071083B2 (en) | 2017-02-03 | 2018-09-11 | Ovid Therapeutics Inc | Use of gaboxadol in the treatment of tinnitus |
| US20180338959A1 (en) | 2017-05-24 | 2018-11-29 | Ovid Therapeutics Inc. | Treatment of depressive disorders |
| US10813918B2 (en) | 2017-08-04 | 2020-10-27 | Ovid Therapeutics Inc. | Use of Gaboxadol in the treatment of diabetes and related conditions |
| AU2019345312A1 (en) | 2018-09-20 | 2021-03-25 | Ovid Therapeutics Inc. | Use of gaboxadol for the treatment of tourette syndrome, tics and stuttering |
| WO2020106927A1 (en) | 2018-11-21 | 2020-05-28 | Certego Therapeutics | Gaboxadol for reducing risk of suicide and rapid relief of depression |
| CN113423399A (zh) | 2018-12-17 | 2021-09-21 | 奥维德医疗公司 | 加波沙朵用于治疗非24小时睡眠-觉醒障碍的用途 |
| MX2022014599A (es) | 2020-05-20 | 2022-12-16 | Certego Therapeutics Inc | Gaboxadol deuterado en anillo y su uso para el tratamiento de trastornos psiquiatricos. |
| CN114292224B (zh) * | 2022-03-07 | 2022-05-20 | 中国农业科学院农产品加工研究所 | 一种大麻二酚-2-(n-乙酰基)哌啶酸酯及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2784190A (en) * | 1952-03-28 | 1957-03-05 | Upjohn Co | Alkyl piperidinepropionates |
| CA762455A (en) * | 1962-03-22 | 1967-07-04 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Pyrido-pyrimidines |
| US3381016A (en) * | 1966-03-04 | 1968-04-30 | Upjohn Co | Isoxazolo[5, 4-b]pyridine derivatives and a method for their preparation |
| DE2221770A1 (de) * | 1972-05-04 | 1973-11-15 | Bayer Ag | Verfahren zur herstellung von tetrahydropyridinen |
| DK62791A (da) * | 1991-04-09 | 1992-11-09 | Tulip Int As | Fremgangsmaade til saltning af koed samt anlaeg til brug ved udoevelse af fremgangsmaaden |
-
1978
- 1978-06-15 DK DK270278A patent/DK270278A/da unknown
- 1978-06-15 DK DK270378A patent/DK270378A/da unknown
- 1978-06-19 EP EP80106498A patent/EP0028017A1/de not_active Withdrawn
- 1978-06-19 ES ES470912A patent/ES470912A1/es not_active Expired
- 1978-06-19 NO NO782128A patent/NO782128L/no unknown
- 1978-06-19 EP EP78100191A patent/EP0000338B1/de not_active Expired
- 1978-06-19 EP EP78100190A patent/EP0000167A1/de not_active Withdrawn
- 1978-06-19 ZA ZA00783492A patent/ZA783492B/xx unknown
- 1978-06-19 AU AU37244/78A patent/AU3724478A/en active Pending
- 1978-06-19 IE IE1234/78A patent/IE47200B1/en unknown
- 1978-06-19 ZA ZA00783493A patent/ZA783493B/xx unknown
- 1978-06-19 NZ NZ187615A patent/NZ187615A/xx unknown
- 1978-06-19 FI FI781955A patent/FI781955A7/fi not_active Application Discontinuation
- 1978-06-19 ES ES470913A patent/ES470913A1/es not_active Expired
- 1978-06-19 FI FI781954A patent/FI64376C/fi not_active IP Right Cessation
- 1978-06-19 NO NO782127A patent/NO152049C/no unknown
- 1978-06-19 EP EP80106497A patent/EP0027279A1/de not_active Withdrawn
- 1978-06-19 US US05/917,118 patent/US4278676A/en not_active Expired - Lifetime
- 1978-06-20 CA CA305,798A patent/CA1107736A/en not_active Expired
- 1978-06-20 AU AU37298/78A patent/AU521040B2/en not_active Expired
- 1978-06-20 IT IT7868449A patent/IT7868449A0/it unknown
- 1978-06-20 JP JP7479978A patent/JPS5436275A/ja active Pending
- 1978-06-20 JP JP7480078A patent/JPS5436290A/ja active Pending
- 1978-06-20 IT IT68450/78A patent/IT1159739B/it active
- 1978-06-20 AT AT0448678A patent/AT368505B/de not_active IP Right Cessation
-
1979
- 1979-09-03 NO NO792839A patent/NO792839L/no unknown
- 1979-12-17 US US06/104,080 patent/US4301287A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5436275A (en) | Cyclic amino acids | |
| JPS5488291A (en) | Substituteddpenn22mmcarboxylic acids | |
| NZ186679A (en) | 7-substituted-3-cephem-4-carboxylic acids | |
| JPS53130617A (en) | 2 ajido 2 deokishigurikoshirunitoreetomataha haraidooyobisonoseizoho 2 amino mataha2 asetoamido gurikoosunoseizoho oyobigurikoshidooyobisonoseizohoho narabinigaigurikoshidoyorinarumenekikyuchakutai | |
| PH16587A (en) | Fluorinated amino acids | |
| AU4258178A (en) | Peptide derivatives | |
| CA1109861A (en) | 2-methylpenem-3-carboxylic acids | |
| NZ187534A (en) | Ethynyl - aminoacetic acids | |
| ZA783699B (en) | Peptides | |
| GR64495B (en) | Novel fluorinated amino acids | |
| ZA783353B (en) | A-acetylenic amino acid derivatives | |
| GB2001958B (en) | Mercaptoacylamidobenzoyl glycine | |
| JPS5398983A (en) | Oreandomycine 44substituted amino derivative | |
| ZA783273B (en) | A-halomethyl amino acids | |
| GB2001626B (en) | Alpha-halomethyl dericatives of amino acids | |
| GB2001309B (en) | Alpha-halomethyl amino acid derivatives | |
| GB2001061B (en) | -vincly amino acids | |
| ZA783368B (en) | A-vinyl amino acid derivatives | |
| ZA781127B (en) | 1-azaxanthone-3-carboxylic acids | |
| GB2006800B (en) | Aliphatic polyamides | |
| JPS52153946A (en) | Cyclic amino acid | |
| GB2001060B (en) | A-acetylenic amino acids | |
| AU3592478A (en) | Acids 5-alkylsulphonyl- and 5-alkenylsulphonylbarbituric | |
| IL59481A0 (en) | -halomethyl amino acids | |
| JPS5287142A (en) | New cyclic amino acid |